[Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk].
Ducceschi
V
V
Cattedra di Cardiologia, Seconda Università degli Studi, Napoli.
Sarubbi
B
B
Esposito
R
R
Manzo
G
G
Mayer
M S
MS
Santangelo
L
L
Iacono
A
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology* / Q000517:prevention & control; D003327:Coronary Disease / Q000503:physiopathology; D004562:Electrocardiography; D004594:Electrophysiology; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology; D012307:Risk Factors; D014665:Vasodilator Agents / Q000627:therapeutic use; D016276:Ventricular Function
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D014665:Vasodilator Agents; D000638:Amiodarone
La dispersione del tempo di recupero ventricolare come nuovo indice di rischio aritmogeno.